NASDAQ:AGIO

Agios Pharmaceuticals Stock Predictions

etoro logo Buy AGIO
*Your capital is at risk
$27.68
+1.17 (+4.41%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AGIO Prediction Chart

AGIO Predictions History

Latest community submissions for AGIO.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 10, 2026 $33.55 +1.90% $32.92 X 98.10% 0
Apr 10, 2026 $33.31 +1.19% $32.92 X 98.81% 1
Tim Chlebek Tim Chlebek @TimChlebek.132173
Apr 10, 2026 Bullish $32.92 X 0
JS JS Pro
Jun 8, 2023 $26.86 -0.63% $26.60 V 99.02% 2
Jun 8, 2023 $26.64 -1.46% $26.60 V 99.87% 6
Jun 8, 2023 $26.78 -0.91% $26.60 V 99.31% 4
Apr 29, 2019 $56.29 -1.42% $57.10 X 98.58% 1
Jan 10, 2017 $38.00 -10.08% $42.26 X 89.90% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AGIO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE